Brainomix
PrivateLast Round
Series C
Extension
Feb 24, 2026
Total Funding Raised
$63.85M
Momentum Score
50 /100
Company Overview
Brainomix is a medical technology company that provides an AI-powered platform with imaging biomarkers to assist clinicians with diagnosis and treatment decisions for stroke, lung fibrosis, and cancer.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Healthcare Analytics, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Subscription SaaS, Government Contracts, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Brainomix Comps
Public and private peers based on sector, stage, and business model.
Brainomix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Feb 24, 2026 | ||||
| Series C | Mar 20, 2025 | ||||
| Series C Extension | Feb 24, 2024 | ||||
| Grant | Oct 12, 2023 | ||||
| Series B | Dec 16, 2021 | ||||
Series A | Apr 3, 2018 |
Key People
Founding team and executive leadership
Brainomix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| University of Oxford Innovation Fund | Series A |
| IP Group | Series C |
| Hostplus Superannuation Fund | Series C Extension, Series C |
| Boehringer Ingelheim Venture Fund | Series C |
| Boehringer Ingelheim Venture Fund | Series A, Series B, Series C |
| Modi Ventures | Series C Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
Monthly visitors increased 36% MoM to 11.5K.
- Mar 11, 2026
West Virginia University Health System deployed its AI imaging platform.
Brainomix Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Brainomix's valuation, stock price, and market status.
